For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
Senate Big Beautiful Bill Contains Needed Medicaid Reforms
The Senate today voted 51 to 50 to pass the Reconciliation package known as the “One Big Beautiful Bill,” following House passage in May.
News Release
Senate Parliamentarian Eliminates Medicaid Reform Provisions, Leaving Costs/Problems Intact
The Senate’s parliamentarian has determined that many of the Medicaid provisions in the One Big Beautiful Bill cannot be passed with simple majority vote via…
Blog
FDA can’t stomach fluoride and doesn’t want you to, either
On May 13, the Food and Drug Administration (FDA) announced that it would begin a process intended to exclude ingestible prescription fluoride products for…
Search Posts
Op-Eds
Trashing Free Trade: The Basel Convention’s Impact on International Commerce
Trashing Free Trade: The Basel Convention’s Impact on International Commerce by James M. Sheehan With the establishment of the World Trade Organization (WTO) in 1995,…
Study
Cardiac and Cancer Specialists on the Need for FDA Reform
Two National Polls Debunk The Notion That FDA Doesn't Need Fixing…
News Release
Listen to CEI’s Radio and TV ads on Drug Lag–the delayed availability of new therapies due to FDA regulation
CEI’s radio ad on FDA’s drug approval system, Ocean Storm, is available at: http://cei.org/sites/default/files/CEI_Radio_Storm.mp3 CEI’s television ad is available at:…
Study
Breaking The FDA’s Drug Approval Monopoly:
Executive Summary The Food and Drug Administration’s monopoly over approving new medical therapies is premised on the idea that information markets fail. In…
Op-Eds
Nailed by FDA
I started 1996 with two new experiences. I had a close-up photograph taken of my big toe, and I had my first personal run-in with…
Products
Rachel Was Wrong
Rachel Carson's Silent Spring ushered in an era of national concern over the potential effects of synthetic chemicals. Published in 1962, Carson's book suggested that…
